Gilead Sciences, Inc.
Long

Gilead Science target level $gild

516
Havin broke out from a long term downtrend as previously posted, they stock is now just at the beginning of a very bullish move to the upside.
Afterhours today the announce that 2 phase 3 studies had begun for a antiviral coronavirus drug .

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.